FLT3 and acute myeloid leukemia: Interestingly, this alteration in signaling promotes AML progression in mice, suggesting that targeting FLT3-ITD depalmitoylation could offer a promising therapeutic strategy, potentially in combination with FLT3 inhibitors [4,13].